Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes. (April 2015)

• Record Type: Journal Article
• Authors: Satin, Leslie S.; Butler, Peter C.; Ha, Joon; Sherman, Arthur S.
• Is Part Of: Molecular aspects of medicine. Volume 42(2015)
• Page Start: 61
• Page End: 77
• Publication Date: 2015-04
• Subjects: Islets -- Oscillations -- Insulin pulsatility -- Insulin resistance -- Diabetes; Pathology, Molecular -- Periodicals; Medicine -- Periodicals; Biochemistry -- Periodicals; Medicine -- Periodicals; Molecular Biology -- Periodicals; Pathologie moléculaire -- Périodiques; Médecine -- Périodiques; Electronic journals; 612.015
• DOI: 10.1016/j.mam.2015.01.003
• Languages: English
• ISSNs: 0098-2997

Abstract

Abstract: Type 2 diabetes (T2DM) results when increases in beta cell function and/or mass cannot compensate for rising insulin resistance. Numerous studies have documented the longitudinal changes in metabolism that occur during the development of glucose intolerance and lead to T2DM. However, the role of changes in insulin secretion, both amount and temporal pattern, has been understudied. Most of the insulin secreted from pancreatic beta cells of the pancreas is released in a pulsatile pattern, which is disrupted in T2DM. Here we review the evidence that changes in beta cell pulsatility occur during the progression from glucose intolerance to T2DM in humans, and contribute significantly to the etiology of the disease. We review the evidence that insulin pulsatility improves the efficacy of secreted insulin on its targets, particularly hepatic glucose production, but also examine evidence that pulsatility alters or is altered by changes in peripheral glucose uptake. Finally, we summarize our current understanding of the biophysical mechanisms responsible for oscillatory insulin secretion. Understanding how insulin pulsatility contributes to normal glucose homeostasis and is altered in metabolic disease states may help improve the treatment of T2DM.